PubMed Health⌕ Search

PubMed · 7140331

Indwelling chemical sensors based on semiconductor technology.

Abstract

Indwelling chemical sensors have been designed and built which operate on similar principles to field effect transistors, the fundamental structural unit of the computer. By appropriate use of ion-filtering membranes with these devices, it is possible to measure, continuously, serum electrolytes, including hydrogen ion, and CO2 tension. Semiconductor processing techniques allow incorporation of multiple ion sensors on a single miniaturized chip. Chip-based signal processing can also allow compensation for temperature effects and other sources of instability. Because these devices can be produced inexpensively, they seem to be promising for patient monitoring in the critical care environment. Problems with stability, blood compatibility, and reference electrode design are addressed and potential solution methods are proposed. The performance of preliminary devices in vitro and in vivo is discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R C Eberhart, T H Thomasson, M S Munro, A Kumar, G Szabo. 1982. Indwelling chemical sensors based on semiconductor technology.. https://doi.org/10.1097/00003246-198212000-00007

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.

Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) is the precursor of Delta9-tetrahydrocannabinol (Delta9-THC) in hemp plants. During smoking, the non-psychoactive Delta9-THCA-A is converted to Delta9-THC, the main psychoactive component of marihuana and hashish. Although the decarboxylation of Delta9-THCA-A to Delta9-THC was assumed to be complete--which means that no Delta9-THCA-A should be detectable in urine and blood serum of cannabis consumers--we found Delta9-THCA-A in the urine and blood serum samples collected from police controls of drivers suspected for driving under the influence of drugs (DUID). For LC-MS/MS analysis, urine and blood serum samples were prepared by solid-phase extraction. Analysis was performed with a phenylhexyl column using gradient elution with acetonitrile. For detection of Delta9-THCA-A, the mass spectrometer (MS) (SCIEX API 365 triple-quadrupole MS with TurboIonSpray source) was operated in the multiple reaction monitoring (MRM) mode using the following transitions: m/z357 --> 313, m/z357 --> 245 and m/z357 --> 191. Delta9-THCA-A could be detected in the urine and blood serum samples of several cannabis consumers in concentrations of up to 10.8 ng/ml in urine and 14.8 ng/ml in serum. The concentration of Delta9-THCA-A was below the Delta9-THC concentration in most serum samples, resulting in molar ratios of Delta9-THCA-A/Delta9-THC of approximately 5.0-18.6%. Only in one case, where a short elapsed time between the last intake and blood sampling is assumed, the molar ratio was 18.6% in the serum. This indicates differences in elimination kinetics, which need to be investigated in detail.

Blood Chemical Analysis↗